Morgan Stanley Reaffirms “Buy” Rating on Ultragenyx Pharmaceutical (RARE) with $55 PT

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is one of the 15 stocks set to explode in 2026. On November 5, 2025, analyst ...